Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Codexis Announces New Employment Inducement Grants GlobeNewswire - Fri Dec 6, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Tue Nov 19, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis Pioneers Enzymatic Synthesis for siRNA Therapeutics and Demonstrates Superior Performance of Engineered Ligases at TIDES Europe 2024 Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Codexis shares new data on its siRNA therapeutic synthesis methods and performance advantages of its engineered ligases.Quiver AI SummaryCodexis, Inc. has made significant advancements in its Enzyme Catalyzed...

CDXS : 4.93 (-6.63%)
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics GlobeNewswire - Thu Nov 14, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors GlobeNewswire - Tue Nov 12, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics GlobeNewswire - Mon Nov 11, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis Announces New Employment Inducement Grants GlobeNewswire - Fri Nov 8, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis to Participate in Upcoming Healthcare Conferences GlobeNewswire - Mon Nov 4, 3:05PM CST

CDXS : 4.93 (-6.63%)
Codexis: Q3 Earnings Snapshot AP - Thu Oct 31, 3:23PM CDT

Codexis: Q3 Earnings Snapshot

CDXS : 4.93 (-6.63%)
Codexis Reports Third Quarter 2024 Financial Results GlobeNewswire - Thu Oct 31, 3:05PM CDT

CDXS : 4.93 (-6.63%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases Barchart - 1 hour ago
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot